Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
TH International warrant exchange offer
A total of approximately 19,724,988 warrants were exchanged for shares
Akoya Biosciences $50 million follow-on offering
The stock is listed on Nasdaq
Ventas Realty $862.5 million exchangeable senior notes offering
We advised Ventas on the transaction
Aker BP $1.5 billion notes offering
The notes are due 2028 and 2033
Bread Financial Holdings refinancing transactions
We advised Bread Financial on its new credit facilities, its issuance of convertible notes and a tender offer
Bank of America €1 billion green bond offering
The 4.134% investment-grade notes are due 2028
Ionis Pharmaceuticals $575 million convertible senior notes offering
The 1.75% convertible senior notes are due 2028
Mobileye $1.617 billion secondary offering
We advised Mobileye on the registered secondary offering
Mondee Holdings $52.5 million debut secondary equity offering
The shares are listed on Nasdaq